David P. Vogt, MD
General and Liver Transplant Surgery, Transplant Center, and Department of General Surgery, The Cleveland Clinic  

Address: David P. Vogt, MD, Department of General Surgery, A110, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

David P. Vogt, MD
General and Liver Transplant Surgery, Transplant Center, and Department of General Surgery, The Cleveland Clinic  

Address: David P. Vogt, MD, Department of General Surgery, A110, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

David P. Vogt, MD
General and Liver Transplant Surgery, Transplant Center, and Department of General Surgery, The Cleveland Clinic  

Address: David P. Vogt, MD, Department of General Surgery, A110, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Brian F. Mandell, MD, PhD
Deputy Editor

Brian F. Mandell, MD, PhD
Deputy Editor

Brian F. Mandell, MD, PhD
Deputy Editor

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

John D. Clough, MD
Editor in Chief

John D. Clough, MD
Editor in Chief

John D. Clough, MD
Editor in Chief

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.